One size fits all: The story of SGLT2 inhibitors in heart failure

Subodh Verma; Nitish K. Dhingra; Deepak L. Bhatt; Nikolaus Marx; Francesco Cosentino

doi:10.1016/j.medj.2022.10.001

One size fits all: The story of SGLT2 inhibitors in heart failure

Subodh Verma
, Nitish K. Dhingra
, Deepak L. Bhatt
, Nikolaus Marx
, Francesco Cosentino

Research output: Contribution to journal › Comment/debate

6 Scopus citations

Abstract

EMPEROR-Preserved and DELIVER have ushered in a new era for the treatment of heart failure with a preserved ejection fraction (HFpEF). In this commentary, we compare the characteristics and findings of these two trials and assess their implications for the broader management of the heart failure syndrome.

Original language	English
Pages (from-to)	735-739
Number of pages	5
Journal	Med
Volume	3
Issue number	11
DOIs	https://doi.org/10.1016/j.medj.2022.10.001
State	Published - 11 Nov 2022
Externally published	Yes

Access to Document

10.1016/j.medj.2022.10.001

Cite this

@article{31dafed3cf934b2d9a18dcde730b70bd,

title = "One size fits all: The story of SGLT2 inhibitors in heart failure",

abstract = "EMPEROR-Preserved and DELIVER have ushered in a new era for the treatment of heart failure with a preserved ejection fraction (HFpEF). In this commentary, we compare the characteristics and findings of these two trials and assess their implications for the broader management of the heart failure syndrome.",

author = "Subodh Verma and Dhingra, \{Nitish K.\} and Bhatt, \{Deepak L.\} and Nikolaus Marx and Francesco Cosentino",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",

year = "2022",

month = nov,

day = "11",

doi = "10.1016/j.medj.2022.10.001",

language = "English",

volume = "3",

pages = "735--739",

journal = "Med",

issn = "2666-6359",

publisher = "Cell Press",

number = "11",

}

TY - JOUR

T1 - One size fits all

T2 - The story of SGLT2 inhibitors in heart failure

AU - Verma, Subodh

AU - Dhingra, Nitish K.

AU - Bhatt, Deepak L.

AU - Marx, Nikolaus

AU - Cosentino, Francesco

PY - 2022/11/11

Y1 - 2022/11/11

N2 - EMPEROR-Preserved and DELIVER have ushered in a new era for the treatment of heart failure with a preserved ejection fraction (HFpEF). In this commentary, we compare the characteristics and findings of these two trials and assess their implications for the broader management of the heart failure syndrome.

AB - EMPEROR-Preserved and DELIVER have ushered in a new era for the treatment of heart failure with a preserved ejection fraction (HFpEF). In this commentary, we compare the characteristics and findings of these two trials and assess their implications for the broader management of the heart failure syndrome.

UR - https://www.scopus.com/pages/publications/85141639389

U2 - 10.1016/j.medj.2022.10.001

DO - 10.1016/j.medj.2022.10.001

M3 - Comment/debate

C2 - 36309012

AN - SCOPUS:85141639389

SN - 2666-6359

VL - 3

SP - 735

EP - 739

JO - Med

JF - Med

IS - 11

ER -

One size fits all: The story of SGLT2 inhibitors in heart failure

Abstract

Access to Document

Fingerprint

Cite this